Becker's Hospital Review | Healthcare News & Analysis

Author's posts

New York mulls closure of SUNY Downstate

The State of New York is planning to significantly shrink or possibly close University Hospital at Downstate in Brooklyn due to concerns that include low patient volumes, a deteriorating hospital building and an operating deficit of about $100 million,…

Melanoma vaccine shows promise; approved for phase 3 trial

Biotech company Orbis Health Solutions was approved to begin a phase 3 clinical trial of its melanoma vaccine, ABC News reported Jan. 20.

Walmart raises store manager pay to $128K

Walmart will boost store manager base pay by more than $10,000 next month, according to a post on the company’s website.

Why health systems are laying off IT workers

CIOs told Becker’s the recent rash of IT layoffs at health systems isn’t surprising given the financial challenges in healthcare, but that cutting on the tech side can be short-sighted.

Labor board files complaint against Ascension hospital

The National Labor Relations Board regional office has issued a consolidated complaint against Ascension Providence Rochester (Mich.) Hospital, in response to allegations filed by OPEIU Local 40, which represents registered nurses and radiology technol…

Illinois system taps new CFO

Springfield, Ill.-based Hospital Sisters Health System tapped Michael Scialdone as its new senior vice president and CFO, effective Jan. 8. 

3 dead after medical helicopter crash

Three crew members died in a medical helicopter crash in Oklahoma on Jan. 20, according to the air ambulance provider Air Evac Lifeteam.

Nurse accused of dispensing morphine that led to death

A Utah nurse has been indicted for allegedly distributing and dispensing morphine that led to a person’s death last summer.

Intermountain ends precision medicine program

Intermountain Health will end and divest its Precision Genomics Laboratory Feb. 1.

'Faux-zempic': What to know about compounded weight loss drugs

Physicians, drugmakers, obesity organizations and the FDA are fretting about compounded versions of popular weight loss and diabetes drugs, including Wegovy, Ozempic and Zepbound.